Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation.

Huo M, Sahgal A, Pryor D, Redmond K, Lo S, Foote M.

Surg Neurol Int. 2017 Feb 20;8:30. doi: 10.4103/2152-7806.200581. eCollection 2017 Feb 20. Review.

2.

Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation.

Oh D, Hong CS, Ju SG, Kim M, Koo BY, Choi S, Park HC, Choi DH, Pyo H.

Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922.

3.

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016.

Bossé D, Ng T, Ahmad C, Alfakeeh A, Alruzug I, Biagi J, Brierley J, Chaudhury P, Cleary S, Colwell B, Cripps C, Dawson LA, Dorreen M, Ferland E, Galiatsatos P, Girard S, Gray S, Halwani F, Kopek N, Mahmud A, Martel G, Robillard L, Samson B, Seal M, Siddiqui J, Sideris L, Snow S, Thirwell M, Vickers M, Goodwin R, Goel R, Hsu T, Tsvetkova E, Ward B, Asmis T.

Curr Oncol. 2016 Dec;23(6):e605-e614. doi: 10.3747/co.23.3394. Epub 2016 Dec 21.

4.

Stereotactic body radiation therapy induces fast tumor control and symptom relief in patients with iliac lymph node metastasis.

Wang Z, Wang J, Zhuang H, Wang P, Yuan Z.

Sci Rep. 2016 Nov 29;6:37987. doi: 10.1038/srep37987.

5.

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974-2011.

Yu E, Koffer PP, DiPetrillo TA, Kinsella TJ.

Front Oncol. 2016 Sep 12;6:203. doi: 10.3389/fonc.2016.00203. eCollection 2016 Sep 12.

6.

A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer.

Avkshtol V, Dong Y, Hayes SB, Hallman MA, Price RA, Sobczak ML, Horwitz EM, Zaorsky NG.

Res Rep Urol. 2016 Aug 18;8:145-58. doi: 10.2147/RRU.S58262. eCollection 2016 Aug 18. Review.

7.

Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.

Park HC, Yu JI, Cheng JC, Zeng ZC, Hong JH, Wang ML, Kim MS, Chi KH, Liang PC, Lee RC, Lau WY, Han KH, Chow PK, Seong J.

Liver Cancer. 2016 Jul;5(3):162-74. doi: 10.1159/000367766. Epub 2016 May 3.

8.

Optimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular Carcinoma.

Yoon HI, Seong J.

Liver Cancer. 2016 Apr;5(2):139-51. doi: 10.1159/000367762. Epub 2016 Mar 17. Review.

9.
10.

Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.

Oladeru OT, Miccio JA, Yang J, Xue Y, Ryu S, Stessin AM.

J Gastrointest Oncol. 2016 Jun;7(3):433-40. doi: 10.21037/jgo.2015.10.04.

11.

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma.

Paik EK, Kim MS, Jang WI, Seo YS, Cho CK, Yoo HJ, Han CJ, Park SC, Kim SB, Kim YH.

Radiat Oncol. 2016 Feb 19;11:22. doi: 10.1186/s13014-016-0597-7.

12.

Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.

Wild AT, Herman JM, Dholakia AS, Moningi S, Lu Y, Rosati LM, Hacker-Prietz A, Assadi RK, Saeed AM, Pawlik TM, Jaffee EM, Laheru DA, Tran PT, Weiss MJ, Wolfgang CL, Ford E, Grossman SA, Ye X, Ellsworth SG.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):571-9. doi: 10.1016/j.ijrobp.2015.11.026. Epub 2015 Dec 1.

13.

Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study.

Sakaguchi M, Maebayashi T, Aizawa T, Ishibashi N, Fukushima S, Abe O, Saito T.

Radiat Oncol. 2016 Jan 19;11:3. doi: 10.1186/s13014-016-0582-1.

14.

Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: When and Why Is It Appropriate Therapy?

Mullins K.

J Adv Pract Oncol. 2015 Jul-Aug;6(4):351-4. Epub 2015 Jul 1. Review. No abstract available.

15.

SBRT: A viable option for treating adrenal gland metastases.

Ippolito E, D'Angelillo RM, Fiore M, Molfese E, Trodella L, Ramella S.

Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):484-90. doi: 10.1016/j.rpor.2015.05.009. Epub 2015 Jun 19. Review.

16.

Liver metastases and SBRT: A new paradigm?

Comito T, Clerici E, Tozzi A, D'Agostino G.

Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):464-71. doi: 10.1016/j.rpor.2014.10.002. Epub 2014 Nov 6.

17.

SBRT for lung oligometastases: Who is the perfect candidate?

Navarria P, De Rose F, Ascolese AM.

Rep Pract Oncol Radiother. 2015 Nov-Dec;20(6):446-53. doi: 10.1016/j.rpor.2014.11.005. Epub 2014 Nov 30.

18.

Additional data in the debate on stage I non-small cell lung cancer: surgery versus stereotactic ablative radiotherapy.

Simone CB 2nd, Dorsey JF.

Ann Transl Med. 2015 Aug;3(13):172. doi: 10.3978/j.issn.2305-5839.2015.07.26.

19.
20.

Robotic radiosurgery in pancreatic cancer: A systematic review.

Buwenge M, Cellini F, Silvestris N, Cilla S, Deodato F, Macchia G, Mattiucci GC, Valentini V, Morganti AG.

World J Gastroenterol. 2015 Aug 21;21(31):9420-9. doi: 10.3748/wjg.v21.i31.9420. Review.

Supplemental Content

Support Center